2F8-10036-19442
2 vaccinations
9 coded responses
24 check-ins
9 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 31-35
- ZIP prefix
- 100 / NY
- Registered
- 2021-01-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-05
Dose 1 — Moderna
-
2021-01-08
Registered in v-safe
- 2021-01-08
- 2021-01-09
- 2021-01-10
- 2021-01-11
- 2021-01-12
-
2021-01-19
Survey response — day 14, dose 1MedDRA: Lymphadenopathy — Feeling: GoodFree text: L supraclavicular lymphadenopathy (L delt was injected) about a week ago which while still present seems to have started improving todayMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-26
- 2021-02-02
-
2021-02-04
Dose 2 — Moderna
- 2021-02-04
-
2021-02-05
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Fatigue or tirednessAdult check-in
-
2021-02-06
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: L supraclavicular lymphadenopathy (injected L delt)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-07
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: L supraclavicular lymphadenopathy (L delt injected)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-08
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: L supraclavicular lymphadenopathyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-09
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: L supraclavicular lymphadenopathyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-10
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: L supraclavicular lymphadenopathyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-11
Survey response — day 7, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: L supraclavicular lymphadenopathyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-18
- 2021-02-25
- 2021-03-04
- 2021-03-11
- 2021-03-18
-
2021-05-06
Survey response — 3 months, dose 2MedDRA: Pharyngitis streptococcal, SARS-CoV-2 test negative — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Diagnosed with strep pharyngitis- tested + on a rapid test. My covid rapid and PCR were negative.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-06
Report sent to call center — 3 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-05
-
2022-02-04
Survey response — 12 months, dose 2MedDRA: Influenza A virus test positive — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Tested + for flu A 12/24. Better at this timeMedDRA releases: 2024-11 · check-in free text available
-
2022-02-04
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-02-09
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-05 | Moderna | |
| 2 | 2021-02-04 | Moderna |
Call center
2 call center cases
2 successful
Free text
Release 2 — day 14, dose 1
Symptoms: L supraclavicular lymphadenopathy (L delt was injected) about a week ago which while still present seems to have started improving today
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): L supraclavicular lymphadenopathy (injected L delt)
Systemic reaction (other): L supraclavicular lymphadenopathy (L delt injected)
Systemic reaction (other): L supraclavicular lymphadenopathy
Systemic reaction (other): L supraclavicular lymphadenopathy
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): L supraclavicular lymphadenopathy
Release 4 — day 7, dose 2
Systemic reaction (other): L supraclavicular lymphadenopathy
Release 8 — 3 months, dose 2
Symptoms: Diagnosed with strep pharyngitis- tested + on a rapid test. My covid rapid and PCR were negative.
Release 11 — 12 months, dose 2
Symptoms: Tested + for flu A 12/24. Better at this time
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Influenza A virus test positive | · | · | ✓ |
| SD | Lymphadenopathy | ✓ | ✓ | ✓ |
| SD | Pharyngitis streptococcal | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test negative | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release